Generic Drug Makers To Pay $447M Over Fixed Prices
The U.S. Department of Justice said Friday that three pharmaceutical companies accused of fixing generic drug prices have agreed to pay a total of $447.2 million over payments government programs made...To view the full article, register now.
Already a subscriber? Click here to view full article